Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often ...

Add Yahoo as a preferred source to see more of our stories on Google. Tatiana Schlossberg's surprising revelation that she is battling terminal cancer has put a spotlight on the type of cancer with ...

A 27-year-old woman has thanked generous strangers for raising over $133,000 almost overnight so she can undergo potentially ...

Menin inhibitors reshape AML care, boosting targeted options for KMT2A- and NPM1-mutant disease, with promising frontline ...

The company flagged “potent” preclinical data for its AML drug SLS009 ahead of the AACR 2026 conference. ・CEO Angelos ...

For decades, 7+3—consisting of cytarabine plus an anthracycline—has been the backbone of induction therapy for fit adults ...

Acute myeloid leukemia (AML) is a cancer of the bone marrow and the blood that progresses rapidly without treatment. The National Cancer Institute estimates 20,800 new cases of AML will be diagnosed ...

A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group ...

WASHINGTON, Jan. 14, 2026 /PRNewswire/ -- Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment in a new sub-study of its Beat ...

Investors compared Merck’s willingness to pay a 42% premium for mid-stage leukemia drug TERN-701 with Sellas’ AML pipeline ...

Tatiana Schlossberg's surprising revelation that she is battling terminal cancer has put a spotlight on the type of cancer with which she was diagnosed, acute myeloid leukemia. Schlossberg, the ...